Drew M. Diaz 

CEO of Heart Test Laboratories

Mr. Diaz came to Heart Test Laboratories after leaving the US based medical device company, Criticare Systems Inc., a manufacturer of patient monitoring equipment. Upon leaving the company Mr. Diaz was serving as the Senior Vice President of Global Sales. Having held various positions in global companies, the last eleven with Criticare Systems Inc, Mr. Diaz has over twenty years of domestic and international medical device management and marketing experience, in addition to a deep understanding of development and strategic planning of medical exports. Knowledge in opening new markets and driving revenue in a global economy has been critical in the growth of the companies Mr. Diaz has worked for. Mr. Diaz was the Managing Director of Medical Logistics GMbH in Bad Homburg Germany before it was sold to Criticare Systems Inc. Mr. Diaz is a graduate of Texas A&M University and has attended the Executive Education program at Harvard Business School in 2006.

 

Warren M. Dillard

President, CEO, Director of Vanguard Energy

Over several decades Mr. Dillard has established a record of success in the formation and growth of public and private companies. Most recently he served as a senior officer and director of Enercor, a company that has assembled over 40,000 acres of oil and gas leases with significant reserves in the western US. He is also a director of Surge Energy, a publicly traded oil and gas company. Previously, he received additional oil and gas industry experience with Mobil Oil Company.

He has an extensive background in all aspects of the capital markets and finance. He has been involved in numerous development-stage companies and served as the Senior Vice President and CFO of Pepperdine University for seven years.

Prior to earning an MBA with honors from the Harvard Business School, Mr. Dillard graduated from Texas A & M University with a degree in accounting. He is a former chairman of the Southern California Harvard Business School Association.

 

Ilan Reich 

President & CEO of Vizio Medical Devices LLC

Vizio has licensed and developed proprietary microfluidic technology for separating plasma from blood on a macro scale for nephrology, cardiology and oncology uses. The first devices (currently in the testing phase) are for ambulatory and nocturnal removal of excess fluid from patients with chronic kidney disease or congestive heart failure. Another device arising from the same technology platform is an oncology treatment system which aims to improve the safety and/or efficacy of chemotherapy drugs by augmenting the often-slow natural elimination of toxins. Fortune published a profile about my career in the June 11, 2007 issue entitled “The Rise and Fall (and Subsequent Fall and Rise) of Ilan K. Reich”.